Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Thalassemia Market to reach USD 3.81 billion by the end of 2029.

Global Thalassemia Market Size study & Forecast, by Therapeutic Class (Iron Chelating Drugs), by Pipeline (Gene Therapy) and Regional Analysis, 2022-2029

Product Code: HLSMD-30904879
Publish Date: 2-05-2023
Page: 200

Global Thalassemia Market is valued approximately USD 2.58 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. According to Centers for Disease Control and Prevention – Thalassemia can be defined as an inherited blood disorder caused when the body doesn’t make enough hemoglobin. Hemoglobin is an important part of red blood cells. Thalassemia is a treatable disorder that can be well-managed with blood transfusions and chelation therapy. There are different types of signs and symptoms associated with thalassemia including Fatigue. Weakness, Pale or yellowish skin, Facial bone deformities, Slow growth, Abdominal swelling., and Dark urine among others. The increasing prevalence of blood disorders and growing adoption of blood transfusion and iron chelation therapies are key factors driving the market growth.

The increasing prevalence of blood disorders is contributing towards the growth of the Global Thalassemia Market. For instance – according to Indian Academy of Pediatrics (IPA) estimates – as of 2021, approximately 10% of the total world incidence of thalassemia-affected children and one in eight of thalassemia carriers live in India. Additionally, as per World Health organization (WHO) estimates – Beta-thalassemia affects 2.9% of the world’s population. Also, growing healthcare industry in developing regions and increasing number of clinical trials for blood disorders would create lucrative growth prospectus for the market over the forecast period. However, the high cost associated with Thalassemia treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Thalassemia Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the growing incidences of thalassemia and rise in spending in health infrastructure in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and growing incidences of blood related disorders as well as rapid expansion of contract manufacturing organizations in the region.

Major market player included in this report are:
Bluebird Bio Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Novartis AG

Recent Developments in the Market:
Ø In August 2022, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy intended for the treatment of adult and pediatric patients affected by beta-thalassemia.

Global Thalassemia Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Therapeutic Class, Pipeline, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Class
Iron Chelating Drugs

By Pipeline
Gene Therapy

By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Thalassemia Market, by Region, 2019-2029 (USD Billion)
1.2.2. Thalassemia Market, by Therapeutic Class, 2019-2029 (USD Billion)
1.2.3. Thalassemia Market, by Pipeline, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Thalassemia Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Thalassemia Market Dynamics
3.1. Thalassemia Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Increasing prevalence of blood disorders Growing adoption of blood transfusion and iron chelation therapies
3.1.2. Market Challenges High Cost associated with treatment of Thalassemia
3.1.3. Market Opportunities Growing healthcare industry in developing regions Increasing number of clinical trials for blood disorders
Chapter 4. Global Thalassemia Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Thalassemia Market, by Therapeutic Class
6.1. Market Snapshot
6.2. Global Thalassemia Market by Therapeutic Class, Performance – Potential Analysis
6.3. Global Thalassemia Market Estimates & Forecasts by Therapeutic Class 2019-2029 (USD Billion)
6.4. Thalassemia Market, Sub Segment Analysis
6.4.1. Iron Chelating Drugs
Chapter 7. Global Thalassemia Market, by Pipeline
7.1. Market Snapshot
7.2. Global Thalassemia Market by Pipeline, Performance – Potential Analysis
7.3. Global Thalassemia Market Estimates & Forecasts by Pipeline 2019-2029 (USD Billion)
7.4. Thalassemia Market, Sub Segment Analysis
7.4.1. Gene Therapy
Chapter 8. Global Thalassemia Market, Regional Analysis
8.1. Thalassemia Market, Regional Market Snapshot
8.2. North America Thalassemia Market
8.2.1. U.S. Thalassemia Market Therapeutic Class breakdown estimates & forecasts, 2019-2029 Pipeline breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Thalassemia Market
8.3. Europe Thalassemia Market Snapshot
8.3.1. U.K. Thalassemia Market
8.3.2. Germany Thalassemia Market
8.3.3. France Thalassemia Market
8.3.4. Spain Thalassemia Market
8.3.5. Italy Thalassemia Market
8.3.6. Rest of Europe Thalassemia Market
8.4. Asia-Pacific Thalassemia Market Snapshot
8.4.1. China Thalassemia Market
8.4.2. India Thalassemia Market
8.4.3. Japan Thalassemia Market
8.4.4. Australia Thalassemia Market
8.4.5. South Korea Thalassemia Market
8.4.6. Rest of Asia Pacific Thalassemia Market
8.5. Latin America Thalassemia Market Snapshot
8.5.1. Brazil Thalassemia Market
8.5.2. Mexico Thalassemia Market
8.5.3. Rest of Latin America Thalassemia Market
8.6. Rest of The World Thalassemia Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bluebird Bio Inc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.2.2. Acceleron Pharma, Inc.
9.2.3. Celgene Corporation
9.2.4. GlaxoSmithKline plc
9.2.5. Incyte Corporation
9.2.6. Gamida Cell
9.2.7. Kiadis Pharma
9.2.8. La Jolla Pharmaceutical Company
9.2.9. IONIS Pharmaceuticals
9.2.10. Novartis AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now